江蘇國泰(002091.SZ):擬參與競拍上海嘉定區辦公用地 用以建設國泰創新設計中心
格隆匯6月5日丨江蘇國泰(002091.SZ)公佈,公司第八屆董事會第六次(臨時)會議審議通過《關於下屬子公司參與土地競拍使用權的議案》,同意全資子公司紫金科技的全資子公司上海漫越貿易擬參與競拍購買土地使用權。
宗地位於上海市嘉定區江橋鎮,東至臨洮路,南至華江公路,西至高潮路,北至雙陽港;土地面積63365.8m2;土地用途為辦公樓;土地使用年限50年;土地掛牌價格為7.6039億元。
公司表示,此次下屬子公司購買土地擬實施國泰創新設計中心建設項目(暫定名),是根據公司發展需求,是公司產業佈局業務的重要環節,將有利於發揮公司綜合業務優勢。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.